Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular
Free webinar: Telepathology: is there added value in LMICs?
Free webinar: Telepathology: is there added value in LMICs?

TRAIL induced apoptosis for cancer stem cells

Prof Waleed Arafat - Alexandria Faculty of Medicine, Alexandria, Egypt
TRAIL induced apoptosis for cancer stem cells ( Prof Waleed Arafat - Alexandria Faculty of Medicine, Alexandria, Egypt )
12 Oct 2016

Carcinoid syndrome

Dr Rachel Riechelmann - Instituto do Câncer do Estado de São Paulo, São Paulo, Brazil
Carcinoid syndrome ( Dr Rachel Riechelmann - Instituto do Câncer do Estado de São Paulo, São Paulo, Brazil )
12 Oct 2016

Who should receive combination therapy for ER positive breast cancer?

Dr Michael Gnant - Medizinischen Universität Wien, Vienna, Austria
Who should receive combination therapy for ER positive breast cancer? ( Dr Michael Gnant - Medizinischen Universität Wien, Vienna, Austria )
12 Oct 2016

Positive lessons of negative trials

Dr Bishal Gyawali - Nagoya University, Nagoya, Japan
Positive lessons of negative trials ( Dr Bishal Gyawali - Nagoya University, Nagoya, Japan )
12 Oct 2016

Drug repurposing of propranolol

Dr Pan Pantziarka - Anticancer Fund, UK
Drug repurposing of propranolol ( Dr Pan Pantziarka - Anticancer Fund, UK )
12 Oct 2016

ESMO 2016 conference highlights

Dr Bishal Gyawali - Nagoya University, Nagoya, Japan
ESMO 2016 conference highlights ( Dr Bishal Gyawali - Nagoya University, Nagoya, Japan )
12 Oct 2016

Risk of serious and fatal adverse events with sorafenib use in patients with solid cancers

Dr Bishal Gyawali - Nagoya University, Nagoya, Japan
Risk of serious and fatal adverse events with sorafenib use in patients with solid cancers ( Dr Bishal Gyawali - Nagoya University, Nagoya, Japan )
12 Oct 2016

Combination of MEDI0680, an anti-PD-1 antibody, with durvalumab, an anti-PD-L1 antibody:

Dr Omid Hamid - The Angeles Clinic, California, USA
Combination of MEDI0680, an anti-PD-1 antibody, with durvalumab, an anti-PD-L1 antibody: ( Dr Omid Hamid - The Angeles Clinic, California, USA )
12 Oct 2016

LUME study of nintedanib finds improved PFS, but no overall survival boost

Prof Eric Van Cutsem - University of Leuven, Leuven, Belgium
LUME study of nintedanib finds improved PFS, but no overall survival boost ( Prof Eric Van Cutsem - University of Leuven, Leuven, Belgium )
12 Oct 2016

Left versus right sided GI tumour response in the CRYSTAL trial

Prof Eric Van Cutsem - University of Leuven, Leuven, Belgium
Left versus right sided GI tumour response in the CRYSTAL trial ( Prof Eric Van Cutsem - University of Leuven, Leuven, Belgium )
10 Oct 2016

Looking for new pathways in colorectal cancer

Prof Nils Brünner - Copenhagen University, Copenhagen, Denmark
Looking for new pathways in colorectal cancer ( Prof Nils Brünner - Copenhagen University, Copenhagen, Denmark )
10 Oct 2016

Caring for lung cancer patients

Dr Mark Doherty - Princess Margaret Hospital, Toronto, Canada
Caring for lung cancer patients ( Dr Mark Doherty - Princess Margaret Hospital, Toronto, Canada )
10 Oct 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation